Related Experiment Video
Updated: Feb 24, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Pathobiology of Lp(a) in calcific aortic valve disease
Patrick Mathieu1, Benoit J Arsenault2, Marie-Chloé Boulanger1
1a Laboratory of Cardiovascular Pathobiology, Quebec Heart and Lung Institute/Research Center, Department of Surgery , Laval University , Quebec , QC , Canada.
Introduction:
Calcific aortic valve disease (CAVD) is the most prevalent heart valve disorder. Gene variant in the LPA gene, which encodes for apolipoprotein(a), has been associated at the genome-wide level with CAVD. The process whereby Lp(a) promotes the development of CAVD is under intensive investigation and recent data have shed important insights into disease biology. In this regard, autotaxin (ATX), a lysophospholipase D, interacts with Lp(a) and promotes the mineralization of the aortic valve. Areas covered: In this paper, we are reviewing the biology of Lp(a) and the latest discoveries about the molecular processes that link this lipoprotein with the development of CAVD including the role of ATX. Expert commentary: Elevated Lp(a) levels are genetically determined and considered as an important risk factor for CAVD. Understanding how Lp(a) promotes the development/progression of CAVD is crucial as it may hold promise for the development of new therapies.
Related Concept Videos
Aortic Regurgitation I: Introduction
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology

